See In Application
Flag

Inflation and Higher-for-Longer Rates

March CPI rose 0.9% month on month and 3.3% annually, the fastest monthly gain in nearly four years. Tariff pass-through and energy costs are reducing prospects for Fed easing, keeping financing costs elevated and pressuring consumption-sensitive sectors and capital investment plans.

Flag

Strategic Export Controls Expansion

Beijing is broadening export-control tools beyond rare earths to dual-use inputs and potentially advanced solar manufacturing equipment. This widens disruption risks for downstream manufacturing, energy, and technology investments, while increasing uncertainty over licensing timelines, equipment procurement, and long-term reliability of Chinese industrial inputs.

Flag

Data Protection Compliance Expansion

India’s Digital Personal Data Protection regime has extraterritorial reach and can apply to foreign firms serving Indian users. Penalties can reach ₹250 crore per breach, increasing compliance costs for SaaS, fintech, e-commerce, healthcare, and digital platforms handling Indian personal data.

Flag

Selective Tariff Liberalization Strategy

India is reducing duties on key industrial inputs, EV battery materials, electronics components and life-saving medicines while preserving high protection in sensitive sectors. This mixed regime supports domestic manufacturing, but requires foreign firms to navigate sector-specific tariff advantages and restrictions.

Flag

Supply Chain Security Crackdown

New Chinese rules let authorities investigate foreign firms for shifting sourcing abroad under political pressure, inspect records and potentially restrict departures. The measures materially raise operational, legal and restructuring risk for multinationals pursuing China-plus-one strategies or supplier exits.

Flag

Critical Materials Chokepoint Exposure

Industrial gases and chemical feedstocks have become a major vulnerability beyond crude oil. Korea sources 64.7% of helium from Qatar and 97.5% of bromine from Israel, threatening semiconductor and pharmaceutical production, increasing procurement costs, and prompting emergency stockpiling and supplier diversification.